Get started
Author

Mark O’Carroll

Observed names: M R O'Carroll, M. O'Carroll, M. O’Carroll, M.R. O'Carroll, MR O'Carroll, Mark O'CARROLL, Mark O'Carroll, Mark O′Carroll, O'Carroll, Mark
ORCID: 0009-0009-3904-8590
Observed ORCID: 0009-0009-3904-8590
OpenAlex ID: A5018214803
Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials
2025 · Claire Keating, Lael M Yonker, et al. · The Lancet Respiratory Medicine · 149
PDF
Clonal strains ofPseudomonas aeruginosain paediatric and adult cystic fibrosis units
2004 · M.R. O'Carroll, M.W. Syrmis, et al. · European Respiratory Journal · 116
PDF
Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis
2003 · M R O'Carroll, T J Kidd, et al. · Thorax · 70
PDF
Diagnostic yield of bronchoscopic sampling in febrile neutropenic patients with pulmonary infiltrate and haematological disorders
2011 · A. Seneviratna, M. O'Carroll, et al. · Internal Medicine Journal · 29
Polymyxin B and ethylenediaminetetraacetic acid act synergistically against Pseudomonas aeruginosa and Staphylococcus aureus
2024 · Samuel J. M. Hale, Alan J. Cameron, et al. · Microbiology Spectrum · 17
WS10.03 Inhaled LUNAR®-CFTR mRNA (ARCT-032) is safe and well-tolerated: A phase 1 study
2024 · D.E. Geller, C. Crowley, et al. · Journal of Cystic Fibrosis · 16
Advanced Cystic Fibrosis Lung Disease and Lung Transplantation in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulators
2023 · Mark O'Carroll · Seminars in Respiratory and Critical Care Medicine · 10
Rituximab‐induced interstitial lung disease in a patient with immune thrombocytopenia purpura
2012 · N. Child, M. O'Carroll, et al. · Internal Medicine Journal · 10
Socioeconomic deprivation is not associated with reduced survival of lung transplant recipients
2018 · Andrei M. Beliaev, Peter M. Alison, et al. · Journal of Surgical Research · 8
Late Breaking Abstract - A first-in-human study of ARO-RAGE, an RNAi therapy designed to silence pulmonary RAGE expression
2023 · Mark O'Carroll, John Huetsch, et al. · European Respiratory Journal · 7
WS11.5 Evaluation of combinations of the CFTR potentiator dirocaftor, corrector posenacaftor and amplifier nesolicaftor in cystic fibrosis subjects with two copies of the F508del mutation
2020 · D. G Downey, I. Fajac, et al. · Journal of Cystic Fibrosis · 7
PDF
A First-In-Human Study of ARO-RAGE, A Novel Inhaled RNA-Interference Therapy for Asthma
2024 · M.R. O'Carroll, J.C. Huetsch, et al. · American Journal of Respiratory and Critical Care Medicine · 6
Closure of a Broncho-pleural Fistula Using an Atrial Septal Defect Occluder
2013 · Thomas Pasley, Peter N. Ruygrok, et al. · Heart Lung and Circulation · 4
High prevalence of a class 1 integron-associated aadB gene cassette in Pseudomonas aeruginosa isolates from an Australian cystic fibrosis patient population
2008 · Melanie Syrmis, Scott Bell, et al. · Pathology · 4
120 Vanzacaftor/tezacaftor/deutivacaftor in adolescents and adults with cystic fibrosis: results from two randomized, active-controlled phase 3 trials
2024 · C. Keating, L. Yonker, et al. · Journal of Cystic Fibrosis · 3
Lung transplant in a recipient with tracheal bronchus
2020 · Duvuru Ram, Mark O'Carroll, et al. · Journal of Cardiac Surgery · 3
PDF
Inhaled siRNA therapy targeting RAGE for pulmonary inflammation: a first-in-human randomized trial
2026 · Mark O’Carroll, David Kasahara, et al. · Nature Medicine · 2
Constrictive Pericarditis Post Lung Transplantation: Suspect and Succeed
2025 · A. Roy, A. Sibal, et al. · Heart Lung and Circulation · 2
Lung transplant graft salvage using aortic homograft for bronchial dehiscence
2020 · Duvuru Ram, Geevarghese Mathew, et al. · Interactive Cardiovascular and Thoracic Surgery · 2
PDF
Outcomes following lung transplantation for interstitial lung diseases in New Zealand: a retrospective review
2025 · Jeong Suk Oh, James Rance, et al. · Internal Medicine Journal · 1
283 Safety and tolerability of inhaled LUNAR-CFTR mRNA (ARCT-032) demonstrated in a Phase 1 study
2024 · D. Geller, C. Crowley, et al. · Journal of Cystic Fibrosis · 1
Maxitrol as an antibiofilm agent with potential applications in Otolaryngology‐Head and Neck Surgery
2024 · Samuel J. M. Hale, Raymond Kim, et al. · Laryngoscope Investigative Otolaryngology · 1
Hybrid reconstruction of bronchial dehiscence following lung transplant
2020 · Duvuru Ram, Mark O′Carroll, et al. · Journal of Cardiac Surgery · 1
PDF
Successful pregnancy in a woman with cystic fibrosis and type 2 respiratory failure
2004 · Emma PARRY, Mark O'CARROLL, et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 1
Multi-resistant Pseudomonas aeruginosa (MRPA) in a large adult cystic fibrosis (CF) unit
2003 · Mark O′Carroll, Timothy J. Kidd, et al. · Respirology · 1
Works count: 29
Citation count: 471
H-index: 8
I10-index: 8
Year
Topic
Type